ArticleJournal of translational medicine2024

NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia.

Ying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.